The U.S. healthcare segment is poised for dramatic changes as a result of new political realities. Expansions in coverage for uninsured Americans, new payors, changing regulations, and increasing pressures to control spiraling costs will create both opportunities and threats for medical manufacturers and distributors.
From a strategic point of view, business owners in the fragmented medical technology industry have opportunities to grow through the acquisition of smaller companies, or to sell to larger consolidators. Access to capital will be a key factor in determining which companies remain independent, and which will not. Carbide Partners has the experience to assist a variety of participants in the medtech sector:
Pursuing a strategic plan to build the business into a full-service medical outsourcing company, Mr. Kammert helped identify and review over 60 acquisition candidates. Following the completion of four successful add-on transactions, Mr. Kammert helped lead the sale of the company to a strategic buyer in 2008, realizing a significant capital gain for the company’s private equity investors. See Case Studies: Acquisitions & Corporate Sale — Medical Manufacturing for additional details.